Cuba’s Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials.

Reuters

United Kingdom

Cuba encouraged by early trials of homegrown COVID-19 vaccine

HAVANA (Reuters) -Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials.  Cuba, whose biotech sector https://www.reuters.com/article/uk-health-coronavirus-vaccine-cuba-focus-idUKKBN27S1OZ has exported vaccines for decades, has five vaccine candidates in clinical trials, of which two - Sobera…

Yahoo News

Los Angeles

Los Angeles County

California

United States

Cuba encouraged by early efficacy results of homegrown COVID-19 vaccine

Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials.

Ad Fontes Media

All Sides

Media Bias/Fact Check

The Woodbridge Company

HAVANA (Reuters) -     Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials. Read full story

The Star Kuala Lumpur

Star Media Group

Malaysia

Cuba, whose biotech sector has exported vaccines for decades, has opted not to import foreign vaccines but rather to rely on its own.

Sydney Morning Herald

Nine Entertainment Co.

Sydney

New South Wales

Australia

Cuba encouraged by early results of homegrown COVID-19 vaccine amid worst outbreak

Cuba's Soberana 2 vaccine candidate has shown 62per cent efficacy with just two of its three doses, state-run biopharmaceutical corporation ...

Channel News Asia

Government of Singapore

Singapore

HAVANA -- Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials. Read More

National Post

Leon Cooperman

Allianz

Canada

Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials.
Cuba, whose biotech sector has exported vaccines for decades, has five vaccine candidates in clinical trials, of which two - Soberana 2 and Abdala - are in late phase trials.

WION

Invesco

Noida

Uttar Pradesh

India

Thailand has begun human trials with two of four homegrown vaccine candidates local scientists are developing against COVID-19, as the country scrambles to secure shots from abroad amid its worst wave of infections since the pandemic began.
The homegrown vaccines will not be ready for mass production in time to help Thailand fight off the latest wave.

VOA News

U.S. Agency for Global Media

Thailand Starts Human Trials of Homegrown COVID-19 Vaccines

HAVANA -     Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials.

Today

MEXICO CITY (Sputnik) - The Cuban Soberana 02 vaccine against COVID-19 has an efficacy of over 60 percent, the state-run biopharmaceutical corporation BioCubaFarma...

Sputnik News [🇷🇺-affiliated]

Moscow

Russia

Cuban Soberana 02 Coronavirus Vaccine Demonstrating 62% Efficacy

Vaccinations

International

Americas

Latin America

North America

Vaccines

Coronavirus

Medical

Pandemic

Havana, Cuba

Havana

Cuba

FijiTimes

Euronews

Deccan Herald

U.S. News

Mehr News Agency

SWI swissinfo.ch

Cubadebate

Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses. The news comes as the Caribbean's largest island is facing its worst outbreak since the start of the pandemic. The Communist-run country has opted not to import foreign vaccines but rather to rely on its own.

Cuba encouraged by early trials of homegrown COVID-19 vaccine

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics